Search Share Prices
AZN Shares - A Note On AstraZeneca PLC's (LON:AZN) ROE and Debt To Equity
To keep the lesson grounded in practicality, we'll use ROE to better understand AstraZeneca PLC (LON:AZN). AstraZeneca has a ROE of 14%, based on the last twelve months. That means that for every £1 ...
AstraZeneca and Merck’s Lynparza drug approved by US FDA for pancreatic cancer
“Lynparza is now the only approved targeted medicine in biomarker-selected patients with advanced pancreatic cancer," said AstraZeneca's Dave Fredrickson. AstraZeneca Plc (LON:AZN) announced that the ...
Will these 3 FTSE 100 shares make 20% gains in 2020? Barclays, Taylor Wimpey and AstraZeneca
The performances of FTSE 100 shares Barclays PLC (LON:BARC) (BARC.L), Taylor Wimpey plc (LON:TW) (TW.L) and AstraZeneca plc (LON:AZN) (AZN.L) in 2019 has been strong. All three stocks have made gains ...
AstraZeneca and Daiichi Sankyo's breast cancer treatment gets US approval
AstraZeneca and Daiichi Sankyo are exploring the further potential of Enhertu in HER2-breast cancer with three ongoing Phase III trials The US Food and Drug Administration (FDA) has approved Enhertu, ...
AstraZeneca’s (AZN) Overweight Rating Reiterated at Barclays
Barclays restated their overweight rating on shares of AstraZeneca (LON:AZN) in a research report report published on Friday morning, ThisIsMoney.Co.Uk reports. Several other equities research ...